{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:08:21Z","timestamp":1787044101938,"version":"build-2736575974"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,12]]},"abstract":"\n Background<\/jats:title>\n Genetic variation in complement genes is a predisposing factor for atypical hemolytic uremic syndrome (aHUS), a life-threatening thrombotic microangiopathy, however interpreting the effects of genetic variants is challenging and often ambiguous.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We analyzed 93 complement and coagulation genes in 400 patients with aHUS, using as controls 600 healthy individuals from Iowa and 63,345 non-Finnish European individuals from the Genome Aggregation Database. After adjusting for population stratification, we then applied the Fisher exact, modified Poisson exact, and optimal unified sequence kernel association tests to assess gene-based variant burden. We also applied a sliding-window analysis to define the frequency range over which variant burden was significant.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n We found that patients with aHUS are enriched for ultrarare coding variants in the\n CFH<\/jats:italic>\n ,\n C3<\/jats:italic>\n ,\n CD46<\/jats:italic>\n ,\n CFI<\/jats:italic>\n ,\n DGKE<\/jats:italic>\n , and\n VTN<\/jats:italic>\n genes. The majority of the significance is contributed by variants with a minor allele frequency of <0.1%. Disease-related variants tend to occur in specific complement protein domains of FH, CD46, and C3. We observed no enrichment for multiple rare coding variants in gene-gene combinations.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n \n In known aHUS-associated genes, variants with a minor allele frequency >0.1% should not be considered pathogenic unless valid enrichment and\/or functional evidence are available.\n VTN<\/jats:italic>\n , which encodes vitronectin, an inhibitor of the terminal complement pathway, is implicated as a novel aHUS-associated gene. Patients with aHUS are not enriched for multiple rare variants in complement genes. In aggregate, these data may help in directing clinical management of aHUS.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1681\/asn.2018070759","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T10:55:57Z","timestamp":1540896957000},"page":"2809-2819","source":"Crossref","is-referenced-by-count":65,"title":["Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome"],"prefix":"10.1681","volume":"29","author":[{"given":"Fengxiao","family":"Bu","sequence":"first","affiliation":[{"name":"Medical Genetics Center, Southwest Hospital, Chongqing, China; and"},{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Zhang","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Public Health,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo Ghiringhelli","family":"Borsa","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Jones","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda O.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Takanami","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole C.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Frees","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie P.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Carver College of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Nester","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"},{"name":"Division of Nephrology, Department of Internal Medicine, Carver College of Medicine, and"},{"name":"Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.H.","family":"Smith","sequence":"additional","affiliation":[{"name":"Molecular Otolaryngology and Renal Research Laboratories,"},{"name":"Division of Nephrology, Department of Internal Medicine, Carver College of Medicine, and"},{"name":"Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"B1-20230819","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: State of the art.","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"B2-20230819","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: Conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) controversies conference.","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"B3-20230819","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B4-20230819","doi-asserted-by":"crossref","first-page":"e003573","DOI":"10.1136\/bmjopen-2013-003573","article-title":"A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS).","volume":"3","author":"Rathbone","year":"2013","journal-title":"BMJ Open"},{"key":"B5-20230819","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","article-title":"Atypical hemolytic uremic syndrome.","volume":"33","author":"Kavanagh","year":"2013","journal-title":"Semin Nephrol"},{"key":"B6-20230819","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B7-20230819","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults.","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8-20230819","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","article-title":"An international consensus approach to the management of atypical hemolytic uremic syndrome in children.","volume":"31","author":"Loirat","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B9-20230819","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical HUS.","volume":"129","author":"Jokiranta","year":"2017","journal-title":"Blood"},{"key":"B10-20230819","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2016.99","article-title":"Anti-complement-factor H-associated glomerulopathies.","volume":"12","author":"Durey","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B11-20230819","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B12-20230819","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/hmg\/ddi066","article-title":"Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32.","volume":"14","author":"Esparza-Gordillo","year":"2005","journal-title":"Hum Mol Genet"},{"key":"B13-20230819","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"B14-20230819","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.molimm.2006.08.024","article-title":"Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.","volume":"44","author":"Liszewski","year":"2007","journal-title":"Mol Immunol"},{"key":"B15-20230819","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"B16-20230819","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2013070796","article-title":"Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?","volume":"25","author":"Marinozzi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B17-20230819","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.kint.2017.07.015","article-title":"Complete functional characterization of disease-associated genetic variants in the complement factor H gene.","volume":"93","author":"Merinero","year":"2018","journal-title":"Kidney Int"},{"key":"B18-20230819","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy.","volume":"200","author":"Osborne","year":"2018","journal-title":"J Immunol"},{"key":"B19-20230819","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.4049\/jimmunol.180.9.6385","article-title":"A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity.","volume":"180","author":"Blom","year":"2008","journal-title":"J Immunol"},{"key":"B20-20230819","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1744-313X.2011.01017.x","article-title":"Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome?","volume":"38","author":"Poolpol","year":"2011","journal-title":"Int J Immunogenet"},{"key":"B21-20230819","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000445127","article-title":"Comprehensive analysis of complement genes in patients with atypical hemolytic uremic syndrome.","volume":"43","author":"Zhang","year":"2016","journal-title":"Am J Nephrol"},{"key":"B22-20230819","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"B23-20230819","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fped.2017.00113","article-title":"Unexpected findings in a child with atypical hemolytic uremic syndrome: An example of how genomics is changing the clinical diagnostic paradigm.","volume":"5","author":"Seaby","year":"2017","journal-title":"Front Pediatr"},{"key":"B24-20230819","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.2015101189","article-title":"Thrombotic microangiopathy in inverted formin 2-mediated renal disease.","volume":"28","author":"Challis","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B25-20230819","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00467-015-3110-x","article-title":"Nephrotic syndrome and thrombotic microangiopathy caused by cobalamin C deficiency.","volume":"30","author":"Koenig","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B26-20230819","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2012-2581","article-title":"Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency.","volume":"132","author":"K\u00f6mhoff","year":"2013","journal-title":"Pediatrics"},{"key":"B27-20230819","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00467-010-1609-8","article-title":"CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency.","volume":"25","author":"Bouts","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"B28-20230819","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.molimm.2009.04.012","article-title":"A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome.","volume":"46","author":"St\u00e5hl","year":"2009","journal-title":"Mol Immunol"},{"key":"B29-20230819","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B30-20230819","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10157-010-0375-z","article-title":"A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.","volume":"15","author":"Matsukuma","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"B31-20230819","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1681\/ASN.2015040385","article-title":"High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies.","volume":"27","author":"Bu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B32-20230819","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/jamapsychiatry.2016.0251","article-title":"Exome sequencing of familial bipolar disorder.","volume":"73","author":"Goes","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B33-20230819","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A flexible trimmer for Illumina sequence data.","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"B34-20230819","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B35-20230819","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data.","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"B36-20230819","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The ensembl variant effect predictor.","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"key":"B37-20230819","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00439-017-1779-6","article-title":"The Human Gene Mutation Database: Towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies.","volume":"136","author":"Stenson","year":"2017","journal-title":"Hum Genet"},{"key":"B38-20230819","doi-asserted-by":"crossref","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: Public archive of relationships among sequence variation and human phenotype.","volume":"42","author":"Landrum","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B39-20230819","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools.","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B40-20230819","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","article-title":"A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data.","volume":"27","author":"Li","year":"2011","journal-title":"Bioinformatics"},{"key":"B41-20230819","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/gb-2005-6-5-r44","article-title":"The Sequence Ontology: A tool for the unification of genome annotations.","volume":"6","author":"Eilbeck","year":"2005","journal-title":"Genome Biol"},{"key":"B42-20230819","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease.","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"B43-20230819","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies.","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"key":"B44-20230819","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","article-title":"The variant call format and VCFtools.","volume":"27","author":"Danecek","year":"2011","journal-title":"Bioinformatics"},{"key":"B45-20230819","doi-asserted-by":"crossref","first-page":"e1001322","DOI":"10.1371\/journal.pgen.1001322","article-title":"Testing for an unusual distribution of rare variants.","volume":"7","author":"Neale","year":"2011","journal-title":"PLoS Genet"},{"key":"B46-20230819","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","article-title":"Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies.","volume":"91","author":"Lee","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B47-20230819","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1073\/pnas.91.6.2161","article-title":"Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.","volume":"91","author":"Manchester","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B48-20230819","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/eji.1830220625","article-title":"Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing.","volume":"22","author":"Russell","year":"1992","journal-title":"Eur J Immunol"},{"key":"B49-20230819","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/iub.1203","article-title":"Vitronectin--master controller or micromanager?","volume":"65","author":"Leavesley","year":"2013","journal-title":"IUBMB Life"},{"key":"B50-20230819","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.cb.07.110191.001423","article-title":"Structure and biological role of vitronectin.","volume":"7","author":"Preissner","year":"1991","journal-title":"Annu Rev Cell Biol"},{"key":"B51-20230819","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2249.1995.tb02289.x","article-title":"Complement inhibition by human vitronectin involves non-heparin binding domains.","volume":"101","author":"Sheehan","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"B52-20230819","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2249.1993.tb05956.x","article-title":"Vitronectin-mediated inhibition of complement: Evidence for different binding sites for C5b-7 and C9.","volume":"92","author":"Milis","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"B53-20230819","first-page":"89","article-title":"Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.","volume":"284","author":"Podack","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand Suppl"},{"key":"B54-20230819","doi-asserted-by":"crossref","first-page":"12426","DOI":"10.1073\/pnas.92.26.12426","article-title":"Vitronectin is not essential for normal mammalian development and fertility.","volume":"92","author":"Zheng","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B55-20230819","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1538-7836.2005.01217.x","article-title":"Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation.","volume":"3","author":"Reheman","year":"2005","journal-title":"J Thromb Haemost"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201812000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:34:03Z","timestamp":1786131243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201812000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2018070759","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734324478.793552635","asserted-by":"object"}]},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]}}}